Search our Database of Scientific Publications and Authors

I’m looking for a

    Details and Download Full Text PDF:
    CARD14 Glu138 mutation in familial pityriasis rubra pilaris does not warrant differentiation from familial psoriasis.

    J Dermatol 2016 Feb 1;43(2):187-9. Epub 2015 Jul 1.
    Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
    Some familial cases of pityriasis rubra pilaris (PRP) have the CARD14 gene mutations that are also detected in familial psoriasis vulgaris. However, genotype-phenotype correlation in these two entities is poorly understood. Here, we report a case of PRP with a new mutation in CARD14. Genomic analysis of a 40-year-old female patient with sporadic PRP type V identified a heterozygous dominant c.412G>A mutation (p.Glu138Lys) in CARD14. Two types of CARD14 mutations causing Glu138 substitutions have been reported in cases of familial PRP and pustular psoriasis. All three types, including the present case, are predicted to cause similar loss of the negative charges at this site. This suggests that the difference in molecular charge and the resulting change in molecular interaction around the N-terminal end of the coiled-coil region of CARD14 molecule do not determine the phenotypic differences between psoriasis and PRP.

    Similar Publications

    Intra-familial Variation in Clinical Phenotype of CARD14-related Psoriasis.
    Acta Derm Venereol 2016 Nov;96(7):885-887
    Department of Dermatology, Tel-Aviv Sourasky Medical Center, Weizman str. 6, Tel-Aviv, Israel.
    Psoriasis is a multifactorial chronic inflammatory disease. Monogenic psoriasis has been described recently, including dominantly inherited plaque and generalized pustular types, related to activating mutations in the CARD14 gene. We describe here a family with CARD14-related psoriasis, exhibiting an extreme variability of clinical presentation (from mild plaque-type to generalized pustular psoriasis) and early disease onset. Read More
    The paracaspase MALT1 mediates CARD14-induced signaling in keratinocytes.
    EMBO Rep 2016 06 25;17(6):914-27. Epub 2016 Apr 25.
    Unit of Molecular Signal Transduction in Inflammation, Inflammation Research Center VIB, Ghent, Belgium Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium
    Mutations in CARD14 have recently been linked to psoriasis susceptibility. CARD14 is an epidermal regulator of NF-κB activation. However, the ability of CARD14 to activate other signaling pathways as well as the biochemical mechanisms that mediate and regulate its function remain to be determined. Read More
    Psoriasis mutations disrupt CARD14 autoinhibition promoting BCL10-MALT1-dependent NF-κB activation.
    Biochem J 2016 06 12;473(12):1759-68. Epub 2016 Apr 12.
    The Francis Crick Institute-Mill Hill Laboratory, London, NW7 1AA, U.K.
    Inherited and de novo mutations in the CARD14 gene promote the development of psoriasis, an inflammatory disease of the skin. Caspase recruitment domain-containing protein 14 (CARD14) is a member of the CARMA protein family that includes the structurally related CARD11 adaptor that mediates NF-κB activation by antigen receptors. We investigated the mechanism by which CARD14 mutation in psoriasis activates NF-κB. Read More
    Activating CARD14 Mutations Are Associated with Generalized Pustular Psoriasis but Rarely Account for Familial Recurrence in Psoriasis Vulgaris.
    J Invest Dermatol 2015 Dec 23;135(12):2964-2970. Epub 2015 Jul 23.
    St John's Institute of Dermatology, King's College London, London, UK. Electronic address:
    Caspase recruitment family member 14 (CARD14, also known as CARMA2), is a scaffold protein that mediates NF-κB signal transduction in skin keratinocytes. Gain-of-function CARD14 mutations have been documented in familial forms of psoriasis vulgaris (PV) and pityriasis rubra pilaris (PRP). More recent investigations have also implicated CARD14 in the pathogenesis of pustular psoriasis. Read More